MDT
Medtronic PLC
NYSE: MDT · HEALTHCARE · MEDICAL DEVICES
$90.96
-0.72% today
Updated 2026-09-11
Market cap
$116.35B
P/E ratio
22.57
P/S ratio
3.10x
EPS (TTM)
$4.03
Dividend yield
3.11%
52W range
$73 – $104
Volume
7.5M
Medtronic PLC (MDT) Insider transactions
Net insider activity
Net buying (1,122,778 shares)
Buy transactions
45
Sell transactions
55
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-20 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 1,084 | $92.30 | $100053.20 |
| 2026-08-03 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 40,973 | — | — |
| 2026-08-03 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 14,421 | — | — |
| 2026-08-03 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 5,769 | — | — |
| 2026-08-03 | THOMPSON, KWELI | EVP & President, Neuroscience | Buy | 49,167 | — | — |
| 2026-08-03 | THOMPSON, KWELI | EVP & President, Neuroscience | Buy | 17,306 | — | — |
| 2026-08-03 | THOMPSON, KWELI | EVP & President, Neuroscience | Buy | 6,923 | — | — |
| 2026-08-03 | QUINN, MICHELLE | EVP, GC and Secretary | Buy | 45,070 | — | — |
| 2026-08-03 | QUINN, MICHELLE | EVP, GC and Secretary | Buy | 15,863 | — | — |
| 2026-08-03 | QUINN, MICHELLE | EVP, GC and Secretary | Buy | 6,346 | — | — |
| 2026-08-03 | PIETON, THIERRY | EVP & Chief Financial Officer | Buy | 81,945 | — | — |
| 2026-08-03 | PIETON, THIERRY | EVP & Chief Financial Officer | Buy | 28,842 | — | — |
| 2026-08-03 | PIETON, THIERRY | EVP & Chief Financial Officer | Buy | 11,537 | — | — |
| 2026-08-03 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 295,002 | — | — |
| 2026-08-03 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 273,150 | — | — |
| 2026-08-03 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 103,831 | — | — |
| 2026-08-03 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 41,533 | — | — |
| 2026-08-03 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 77,848 | — | — |
| 2026-08-03 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 27,400 | — | — |
| 2026-08-03 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 46,147 | — | — |
| 2026-08-03 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 10,960 | — | — |
| 2026-08-03 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 65,556 | — | — |
| 2026-08-03 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 23,074 | — | — |
| 2026-08-03 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 9,230 | — | — |
| 2026-08-03 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 1,366 | — | — |
| 2026-08-03 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 2,337 | — | — |
| 2026-08-03 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 2,337 | — | — |
| 2026-07-31 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 1,675 | $85.39 | $143028.25 |
| 2026-07-31 | THOMPSON, KWELI | EVP & President, Neuroscience | Sale | 1,739 | $85.39 | $148493.21 |
| 2026-07-31 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 15,810 | $85.39 | $1.35M |
| 2026-07-31 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 3,356 | $85.39 | $286568.84 |
| 2026-07-31 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 3,074 | $85.39 | $262488.86 |
| 2026-07-31 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 212 | $85.39 | $18102.68 |
| 2026-07-28 | QUINN, MICHELLE | EVP, GC and Secretary | Sale | 2,069 | $86.88 | $179754.72 |
| 2026-07-08 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 3,102 | $83.15 | $257931.30 |
| 2026-06-08 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 3,961 | $80.44 | $318622.84 |
| 2026-06-08 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 228 | $80.45 | $18342.60 |
| 2026-06-05 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 237 | $83.32 | $19746.84 |
| 2026-06-04 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 2,840 | $83.32 | $236628.80 |
| 2026-06-04 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 41,936 | $83.32 | $3.49M |
| 2026-06-04 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 7,471 | $83.32 | $622483.72 |
| 2026-06-04 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 6,817 | $83.32 | $567992.44 |
| 2026-05-26 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 8,449 | — | — |
| 2026-05-26 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Buy | 9,149 | — | — |
| 2026-05-26 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 24,214 | — | — |
| 2026-05-26 | WALL, BRETT A. | EVP & Pres Neuroscience | Buy | 26,907 | — | — |
| 2026-05-26 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 85,461 | — | — |
| 2026-05-26 | MARTHA, GEOFFREY | Director, Chairman and CEO | Buy | 94,963 | — | — |
| 2026-05-26 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 17,093 | — | — |
| 2026-05-26 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Buy | 18,994 | — | — |
| 2026-05-26 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 14,517 | — | — |
| 2026-05-26 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 15,195 | — | — |
| 2026-05-26 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 1,621 | — | — |
| 2026-05-26 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 1,712 | — | — |
| 2026-05-01 | WALTER, MATTHEW R. | SVP, Chief HR Officer | Sale | 35 | $80.00 | $2800.00 |
| 2026-04-28 | POWELL, KENDALL J | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | NABEL, ELIZABETH G | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | LOFTON, KEVIN E | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | LEWIS, GREGORY P | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | HOGAN, RANDALL J | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | FONSECA, LIDIA | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | DONNELLY, SCOTT C | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-28 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 318 | $81.90 | $26044.20 |
| 2026-04-28 | ARNOLD, CRAIG | Director | Sale | 207 | $81.90 | $16953.30 |
| 2026-04-27 | POWELL, KENDALL J | Director | Buy | 2,111 | — | — |
| 2026-04-27 | NABEL, ELIZABETH G | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LOFTON, KEVIN E | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LEWIS, GREGORY P | Director | Buy | 2,111 | — | — |
| 2026-04-27 | LEE, JOON SUP | Director | Buy | 1,803 | — | — |
| 2026-04-27 | JELLISON, WILLIAM R | Director | Buy | 1,444 | — | — |
| 2026-04-27 | HOGAN, RANDALL J | Director | Buy | 2,111 | — | — |
| 2026-04-27 | GROETELAARS, JOHN P | Director | Buy | 1,444 | — | — |
| 2026-04-27 | FONSECA, LIDIA | Director | Buy | 2,111 | — | — |
| 2026-04-27 | DONNELLY, SCOTT C | Director | Buy | 2,111 | — | — |
| 2026-04-27 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Buy | 1,508 | — | — |
| 2026-04-27 | ARNOLD, CRAIG | Director | Buy | 2,111 | — | — |
| 2026-03-03 | PIETON, THIERRY | EVP & Chief Financial Officer | Sale | 2,976 | $96.71 | $287808.96 |
| 2026-02-20 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 340 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 30,568 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 19,923 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 385 | — | — |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 30,568 | $97.66 | $2.99M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Buy | 19,923 | $87.76 | $1.75M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 19,255 | $97.77 | $1.88M |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 1,648 | $97.86 | $161273.28 |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 668 | $97.83 | $65347.10 |
| 2026-02-19 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 385 | $97.82 | $37660.70 |
| 2026-01-29 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 148 | $101.00 | $14948.00 |
| 2025-12-15 | WALL, BRETT A. | EVP & Pres Neuroscience | Sale | 439 | $99.87 | $43842.93 |
| 2025-12-15 | MARTHA, GEOFFREY | Director, Chairman and CEO | Sale | 1,564 | $99.87 | $156196.68 |
| 2025-12-15 | MARINARO, MICHAEL | EVP, Pres MedSurg and Americas | Sale | 1,371 | $99.87 | $136921.77 |
| 2025-12-05 | KIIL, HARRY SKIP | EVP & President Cardiovascular | Sale | 1,702 | $101.36 | $172514.72 |
| 2025-11-20 | BLOMQUIST, DENISE L. | Chief Accounting Officer | Sale | 170 | — | — |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 24,186 | $101.93 | $2.47M |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 1,995 | $102.03 | $203549.85 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 1,942 | $101.99 | $198064.58 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 825 | $102.04 | $84183.00 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 500 | $102.08 | $51040.00 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 325 | $102.06 | $33169.50 |
| 2025-11-19 | SMITH, GREGORY L | EVP Global Ops & Supply Chain | Sale | 227 | $102.05 | $23165.35 |
Frequently asked questions
Are MDT insiders buying or selling?
Over the transactions on record, MDT insiders have been net sellers, with about $17.19M in stock sold across 55 sales, against 1 open-market purchase.
Does insider selling at MDT mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MDT insiders are selling the most?
Recent selling is concentrated in a few names. KIIL, HARRY SKIP accounts for the largest share on record, with about $6.47M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.